Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GlaxoSmithKline Hires Former FDA Top Lawyer Dan Troy As General Counsel

Executive Summary

Former FDA Chief Counsel Daniel Troy will once again be leading a team of lawyers with a drug regulatory focus

You may also be interested in...



FDA Targeting Execs With Criminal Charges For Adulterated/Misbranded Goods

FDA increasingly will prosecute corporate officers in response to criticism over the agency's handling of violations of the Federal Food, Drug & Cosmetic Act in recent years

FDA Targeting Execs With Criminal Charges For Adulterated/Misbranded Goods

FDA increasingly will prosecute corporate officers in response to criticism over the agency's handling of violations of the Federal Food, Drug & Cosmetic Act in recent years

Do Not Be Surprised By Corporate Responsibility Standards - FDA Warns

The standards FDA is reviewing for prosecuting corporate officers deemed responsible for violations they reasonably could have prevented should not catch firms by surprise, according to FDA's litigation chief

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel